Experienced in Generalized Tonic-Clonic Seizure

Mira B. Katan

Basel, BS, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Generalized Tonic-Clonic Seizure
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Mira Katan practices in Basel, Switzerland. Ms. Katan is rated as an Experienced expert by MediFind in the treatment of Generalized Tonic-Clonic Seizure. Her top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Atrial Fibrillation, Diabetes Insipidus (DI), and Thrombectomy.

Her clinical research consists of co-authoring 131 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Generalized Tonic-Clonic Seizure.

Gender
Female

Locations

Basel, BS, Switzerland
Other Locations
Zurich, ZH, Switzerland
Bern, BE, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: Telmisartan, Amlodipine, Indapamide
Study Phase: Phase 3
View 1 Less Clinical Trial

131 Total Publications

Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.
Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.
Journal: JAMA
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Katan's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile